IRAK1 Gene Polymorphism in Rheumatoid Arthritis

Area of Science:

• Genetics
• Immunology
• Rheumatology

Background:

• Rheumatoid arthritis (RA) is a chronic autoimmune disease.
• Interleukin-1 receptor-associated kinase (IRAK1) and cluster of differentiation 40 (CD40) are implicated in RA pathogenesis.
• Previous studies on IRAK1 and CD40 gene polymorphisms in RA have yielded conflicting results.

Purpose of the Study:

• To investigate the association of specific IRAK1 and CD40 gene polymorphisms (rs1059703, rs4810485, rs1883832) with rheumatoid arthritis risk.
• To provide a more accurate estimation of the contribution of these polymorphisms to RA susceptibility.
• To explore the correlation between IRAK1 rs1059703 genotypes and clinical/laboratory features of RA patients.

Main Methods:

• A case-control study involving 200 RA patients and 200 healthy controls.
• Genomic DNA extraction followed by genotyping of three single nucleotide polymorphisms (SNPs) using PCR-RFLP.
• Statistical analysis using chi-square test to evaluate genotype and allele frequencies and their association with RA.

Main Results:

• The T allele and TT/CT genotypes of IRAK1 rs1059703 polymorphism were significantly associated with increased rheumatoid arthritis risk (OR=2.36, P=0.0001 for T allele).
• No significant association was found between CD40 gene polymorphisms (rs1883832, rs4810485) and RA susceptibility.
• IRAK1 rs1059703 genotypes showed significant differences in relation to medical and laboratory features of RA patients.

Conclusions:

• The rs1059703 T allele of the IRAK1 gene is a risk factor for rheumatoid arthritis in the Iranian population.
• This polymorphism is associated with increased RA risk, disease severity, and earlier onset age.
• CD40 gene polymorphisms studied do not appear to contribute significantly to RA risk in this cohort.